Good (mRS ≤2) | Poor (mRS ≥3) | P value | |
---|---|---|---|
(n=19) | (n=25) | ||
Age | 70 | 72 | 0.541 |
Male/female | 12:07 | 13:12 | 0.066 |
Stroke subtypes | |||
LAC/AT/CE (n) | 6/11/2 | 3/11/11 | 0.038 |
Previous stroke, % (n) | 21 (4) | 20 (5) | 1.000 |
Atrial fibrillation, % (n) | 26 (5) | 44 (11) | 0.344 |
Risk factors for arteriosclerosis | |||
Hypertension, % (n) | 68 (13) | 60 (15) | 0.753 |
Diabetes mellitus, % (n) | 26 (5) | 20 (5) | 0.723 |
Hyperlipidemia, % (n) | 32 (6) | 44 (11) | 0.535 |
Number of risk factors | 1.3 | 1.2 | 0.697 |
Baseline NIHSS | 3.7 | 14.1 | 0.001 |
Time from onset to arrival (h) | 15.8 | 12.3 | 0.177 |
Edaravone, % (n) | 74 (14) | 80 (20) | |
8-OHdG concentration (ng/mgCr) | |||
Day 0 | 12.1 ± 6.3 | 13.3 ± 11.2 | 0.538 |
Day 7 | 12.8 ± 6.1 | 17.1 ± 14.1 | 0.205 |
Δ8-OHdG (%) | 2.54 | 39.44 | 0.004 |